MAN17 Apr 2012 08:59
MANROY PLC
US$10.4m (£6.6m) US DEFENCE CONTRACTS
NOVATED TO MANROY USA
Manroy PLC ("Manroy" or the "Group"), the AIM-quoted leading UK manufacturer of heavy machine guns and related products, today announces that the US Department of Defense (the "DoD") has novated a total of US$10.4m (£6.6m) of contracts to Manroy USA ("MUSA" or the "Company"), in which Manroy owns a 49% interest.
The novations are in relation to unfulfilled contracts that formed part of a larger circa US$34m (£21.5m) order placed by the DoD with Sabre Industries ("Sabre"), whose assets were acquired by MUSA in March 2011.
The contract awards include US$7.7m (£4.9m) of M2 Heavy Machine Gun ("HMG") barrels and bolts as well as a further US$2.5m (£1.6m) of M16 weapons, along with orders for M10 Chargers.
Initial production by MUSA to obtain First Article Acceptance ("FAA")* by the DoD for these contracts will commence during April 2012 at MUSA's new 125,000 sq. ft headquarters and manufacturing facility in Spindale, North Carolina. It is anticipated that product deliveries following FAA will commence in August 2012 with the majority of production deliveries being completed during 2013, subject to FAA.
This novation marks a highly important stage in MUSA's development as it follows a lengthy and detailed, but wholly successful, series of audits conducted by the DoD to approve the Company for this significant contract award. The audit procedure covered all aspects of the business including, operations, quality, finance, safety, government property storage and security. As a result, MUSA's Spindale facility is now fully qualified to accept DoD contracts that involve weapons and ammunition. These approvals also qualify the Company to bid for further DoD contracts in the world's largest defence market.
This award follows on from $2.0m (£1.3m) of contract awards won by MUSA over the past few weeks ($1.7m (£1.1m) of which were announced on 22 March 2012), and is a real turning point for the business, with further contract awards anticipated in the near term.